GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (CHIX:COPNz) » Definitions » FCF Margin %

Cosmo Pharmaceuticals NV (CHIX:COPNZ) FCF Margin % : 18.51% (As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Cosmo Pharmaceuticals NV FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cosmo Pharmaceuticals NV's Free Cash Flow for the six months ended in Jun. 2023 was CHF7.9 Mil. Cosmo Pharmaceuticals NV's Revenue for the six months ended in Jun. 2023 was CHF42.6 Mil. Therefore, Cosmo Pharmaceuticals NV's FCF Margin % for the quarter that ended in Jun. 2023 was 18.51%.

As of today, Cosmo Pharmaceuticals NV's current FCF Yield % is 2.07%.

The historical rank and industry rank for Cosmo Pharmaceuticals NV's FCF Margin % or its related term are showing as below:

CHIX:COPNz' s FCF Margin % Range Over the Past 10 Years
Min: -68.97   Med: 5.57   Max: 80.33
Current: 23.02

During the past 13 years, the highest FCF Margin % of Cosmo Pharmaceuticals NV was 80.33%. The lowest was -68.97%. And the median was 5.57%.

CHIX:COPNz's FCF Margin % is ranked better than
93.29% of 1029 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs CHIX:COPNz: 23.02

Cosmo Pharmaceuticals NV FCF Margin % Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV FCF Margin % Chart

Cosmo Pharmaceuticals NV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.23 -57.86 8.04 6.31 25.39

Cosmo Pharmaceuticals NV Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.68 -5.61 24.16 26.23 18.51

Competitive Comparison of Cosmo Pharmaceuticals NV's FCF Margin %

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmo Pharmaceuticals NV's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's FCF Margin % falls into.


Cosmo Pharmaceuticals NV FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cosmo Pharmaceuticals NV's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=25.576/100.748
=25.39 %

Cosmo Pharmaceuticals NV's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=7.884/42.592
=18.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Pharmaceuticals NV FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (CHIX:COPNz) » Definitions » FCF Margin %
Comparable Companies
BSP:GGBR4 BSP:CMIN3 BSP:GOAU3 BSP:FESA3 BSP:PATI3 LLY JNJ MRK ABBV LSE:AZN XSWX:ROG XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568
Traded in Other Exchanges
CMOPF:USA C43:Germany COPN:Switzerland
Address
Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2
Website
https://www.cosmopharma.com
Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Headlines

No Headlines